- Home
- POET vs SVRA Comparison
POET vs SVRA Comparison
Compare POET & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- SVRA
- Stock Information
- Founded
- POET 1972
- SVRA 2007
- Country
- POET Canada
- SVRA United States
- Employees
- POET N/A
- SVRA N/A
- Industry
- POET Semiconductors
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- POET Technology
- SVRA Health Care
- Exchange
- POET Nasdaq
- SVRA Nasdaq
- Market Cap
- POET 450.6M
- SVRA 473.6M
- IPO Year
- POET N/A
- SVRA N/A
- Fundamental
- Price
- POET $5.04
- SVRA $3.04
- Analyst Decision
- POET Strong Buy
- SVRA Buy
- Analyst Count
- POET 2
- SVRA 7
- Target Price
- POET $6.25
- SVRA $5.57
- AVG Volume (30 Days)
- POET 2.2M
- SVRA 1.1M
- Earning Date
- POET 08-11-2025
- SVRA 08-13-2025
- Dividend Yield
- POET N/A
- SVRA N/A
- EPS Growth
- POET N/A
- SVRA N/A
- EPS
- POET N/A
- SVRA N/A
- Revenue
- POET $467,946.00
- SVRA N/A
- Revenue This Year
- POET $8,377.56
- SVRA N/A
- Revenue Next Year
- POET $1,061.73
- SVRA N/A
- P/E Ratio
- POET N/A
- SVRA N/A
- Revenue Growth
- POET 302.50
- SVRA N/A
- 52 Week Low
- POET $2.63
- SVRA $1.89
- 52 Week High
- POET $7.79
- SVRA $4.70
- Technical
- Relative Strength Index (RSI)
- POET 40.40
- SVRA 69.39
- Support Level
- POET $4.90
- SVRA $2.43
- Resistance Level
- POET $5.76
- SVRA $2.77
- Average True Range (ATR)
- POET 0.31
- SVRA 0.20
- MACD
- POET -0.11
- SVRA 0.04
- Stochastic Oscillator
- POET 11.76
- SVRA 71.76
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.